Autor: "Geppert CI" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas.
Autorzy:: Mink JN; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.
Khalmurzaev O; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation, Moscow 115478, Russia.
Pryalukhin A; Institute of Pathology, Saarland University Medical Centre, 66421 Homburg, Germany.
Geppert CI; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Lohse S; Institute of Virology, Saarland University, 66123 Homburg, Germany.
Bende K; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Lobo J; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal.
Henrique R; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal.
Loertzer H; Clinic of Urology and Paediatric Urology, Westpfalz-Klinikum, 67655 Kaiserslautern, Germany.
Steffens J; Department of Urology and Paediatric Urology, St. Antonius Hospital, 52249 Eschweiler, Germany.
Jerónimo C; Department of Pathology and Cancer Biology and Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto/Porto Comprehensive Cancer Center Raquel Seruca, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal.
Wunderlich H; Clinic of Urology and Paediatric Urology, St. Georg Klinikum, 99817 Eisenach, Germany.
Heinzelbecker J; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.
Bohle RM; Institute of Pathology, Saarland University Medical Centre, 66421 Homburg, Germany.
Stöckle M; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.
Matveev V; Department of Urology, Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology', Ministry of Health of the Russian Federation, Moscow 115478, Russia.
Hartmann A; Institute of Pathology, University Erlangen-Nuremberg, 91054 Erlangen, Germany.
Junker K; Department of Urology and Paediatric Urology, Saarland University, 66421 Homburg, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Sep 27; Vol. 15 (19). Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study.
Autorzy:: Stuebs FA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Dietl AK; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Koch MC; Department of Gynecology and Obstetrics, Hospital ANregiomed Ansbach, Escherichstrasse 1, 91522 Ansbach, Germany.
Adler W; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Waldstrasse 6, 91054 Erlangen, Germany.
Geppert CI; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Institute of Pathology, Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Hartmann A; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Institute of Pathology, Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Knöll A; Institute of Clinical and Molecular Virology, Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany.
Mehlhorn G; Gynecology Consultancy Practice, German Cancer Society (DKG) and Committee on Cervical Pathology and Colposcopy (AG-CPC) Certified Gynecological Dysplasia Consultancy Practice, Frauenarztpraxis Erlangen, 91054 Erlangen, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Schulmeyer CE; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Heindl F; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Emons J; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Seibold A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Behrens AS; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Gass P; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Sep 19; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway.
Autorzy:: Yang H; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Universitätsstr. 22, 91504, Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.
Huebner K; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Universitätsstr. 22, 91504, Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.
Hampel C; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Universitätsstr. 22, 91504, Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.
Erlenbach-Wuensch K; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.
Selvamani SB; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, 560100, India.
Shukla V; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, 560100, India.
Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany.; Comprehensive Cancer Center Erlangen‑EMN (CCC ER‑EMN), Östliche Stadtmauerstr. 30, Erlangen, 91054, Germany.
Mahadevan V; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, 560100, India.
Schneider-Stock R; Experimental Tumorpathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Universitätsstr. 22, 91504, Erlangen, Germany. .; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstr. 8-10, Erlangen, 91504, Germany. .; Comprehensive Cancer Center Erlangen‑EMN (CCC ER‑EMN), Östliche Stadtmauerstr. 30, Erlangen, 91054, Germany. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 May 27; Vol. 23 (1), pp. 480. Date of Electronic Publication: 2023 May 27.
Typ publikacji:: Journal Article
MeSH Terms:: Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/genetics
Humans ; Checkpoint Kinase 1/genetics ; Checkpoint Kinase 1/metabolism ; Ataxia Telangiectasia Mutated Proteins/genetics ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Fluorouracil/pharmacology ; DNA Damage ; Activating Transcription Factor 2/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tumor-Stroma Ratio in Colorectal Cancer-Comparison between Human Estimation and Automated Assessment.
Autorzy:: Firmbach D; Digital Health Systems Department, Fraunhofer-Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Benz M; Digital Health Systems Department, Fraunhofer-Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.
Kuritcyn P; Digital Health Systems Department, Fraunhofer-Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.
Bruns V; Digital Health Systems Department, Fraunhofer-Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.
Lang-Schwarz C; Institute of Pathology, Hospital Bayreuth, Preuschwitzer Str. 101, 95445 Bayreuth, Germany.
Stuebs FA; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.; Department of Obstetrics and Gynaecology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Universitätsstraße 21-23, 91054 Erlangen, Germany.
Merkel S; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.; Department of Surgery, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 12, 91054 Erlangen, Germany.
Leikauf LS; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Braunschweig AL; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Oldenburger A; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Gloßner L; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Abele N; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Eck C; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Matek C; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, University Hospital Erlangen, FAU Erlangen-Nuremberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC), University Hospital Erlangen, FAU Erlangen-Nuremberg, Östliche Stadtmauerstr. 30, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 May 09; Vol. 15 (10). Date of Electronic Publication: 2023 May 09.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression.
Autorzy:: Hartmann P; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Trufa DI; Department of Thoracic Surgery, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Hohenberger K; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Tausche P; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Trump S; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Mittler S; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Geppert CI; Institute of Pathology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Rieker RJ; Institute of Pathology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Schieweck O; Laboratory of Clinic Medicine, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.
Sirbu H; Department of Thoracic Surgery, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Finotto S; Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, 91052, Erlangen, Germany. .; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. .; Laboratories of Cellular and Molecular Lung Immunology, Department of Molecular Pneumology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Hartmannstraße 14, 91052, Erlangen, Germany. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Apr 06; Vol. 13 (1), pp. 5662. Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cholesterol*/metabolism
Lung Neoplasms*
Animals ; Triglycerides ; Cholesterol, HDL ; Cholesterol Esters ; ATP Binding Cassette Transporter 1/genetics ; ATP Binding Cassette Transporter 1/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer.
Autorzy:: Ranjan RA; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Clinic and Polyclinic for Internal Medicine II, Klinikum Rechts der Isar, Technische Universität München (TUM), 80333 Munich, Germany.
Muenzner JK; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kunze P; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Ruebner M; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Huebner H; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Fasching PA; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Beckmann MW; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Bäuerle T; Preclinical Imaging Platform Erlangen (PIPE), Institute of Radiology, University Hospital Erlangen-Nuremberg, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Walther W; Experimental Pharmacology & Oncology Berlin-Buch GmbH, 13125 Berlin, Germany.
Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Erber R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Schneider-Stock R; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Mar 10; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A20 as a Potential New Tool in Predicting Recurrence and Patient's Survival in Oral Squamous Cell Carcinoma.
Autorzy:: Spoerl S; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Erber R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Gerken M; Tumor Center, Institute for Quality Management and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.
Taxis J; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Ludwig N; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Nieberle F; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Biermann N; Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Ettl T; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Beckhove P; Division of Interventional Immunology, Leibniz Institute for Immunotherapy, 93053 Regensburg, Germany.
Reichert TE; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Spanier G; Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Spoerl S; Department of Internal Medicine 5-Haematology and Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Jan 21; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 21.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Autorzy:: Mlecnik B; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Inovarion, 75005 Paris, France.
Lugli A; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Bindea G; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Marliot F; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Bifulco C; Department of Pathology, Providence Portland Medical Center, Portland, OR 97213, USA.
Lee JJ; Department of Biostatistics, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
Zlobec I; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Rau TT; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Berger MD; Department of Medical Oncology, University Hospital of Bern, 3010 Bern, Switzerland.
Nagtegaal ID; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Vink-Börger E; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Hartmann A; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Geppert CI; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kolwelter J; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Merkel S; Department of Surgery, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Grützmann R; Department of Surgery, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Van den Eynde M; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires St-Luc, 1200 Brussels, Belgium.; Institut de Recherche Clinique et Experimentale (Pole MIRO), Université Catholique de Louvain, 1200 Brussels, Belgium.
Jouret-Mourin A; Department of Pathology, Cliniques Universitaires St-Luc, 1200 Brussels, Belgium.; Institut de Recherche Clinique et Experimentale (Pole GAEN), Université Catholique de Louvain, 1200 Brussels, Belgium.
Kartheuser A; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Léonard D; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Remue C; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Wang J; Curandis, New York, NY 10583, USA.; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Bavi P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Roehrl MHA; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ohashi PS; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Nguyen LT; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Han S; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
MacGregor HL; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Hafezi-Bakhtiari S; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.
Wouters BG; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Masucci GV; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, 17177 Stockholm, Sweden.
Andersson EK; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, 17177 Stockholm, Sweden.
Zavadova E; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Vocka M; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Spacek J; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Petruzelka L; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Konopasek B; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Dundr P; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Skalova H; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Nemejcova K; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Botti G; Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy.
Tatangelo F; Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy.
Delrio P; Colorectal Surgery Department, Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy.
Ciliberto G; IRCCS Istituto Nazionale Tumori 'Regina Elena', 00128 Rome, Italy.
Maio M; Center for Immuno-Oncology, University Hospital, 53100 Siena, Italy.
Laghi L; Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20090 Milan, Italy.; Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Grizzi F; Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Rozzano, 20090 Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
Fredriksen T; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Buttard B; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Lafontaine L; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Maby P; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Majdi A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
Hijazi A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.
El Sissy C; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Kirilovsky A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Berger A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Digestive Surgery Department, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Lagorce C; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Department of Pathology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Paustian C; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Ballesteros-Merino C; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Dijkstra J; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
van de Water C; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Vliet SVL; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Knijn N; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Mușină AM; Department of Surgical Oncology, Regional Institute of Oncology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iaşi, Romania.
Scripcariu DV; Department of Surgical Oncology, Regional Institute of Oncology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iaşi, Romania.
Popivanova B; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Xu M; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Fujita T; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Hazama S; Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Yamaguchi 755-8505, Japan.
Suzuki N; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, Japan.
Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, Japan.
Okuno K; Department of Surgery, School of Medicine, Kindai University, Osaka-sayama 589-0014, Japan.
Torigoe T; Department of Pathology, Sapporo Medical University, Sapporo 060-8556, Japan.
Sato N; Department of Pathology, Sapporo Medical University, Sapporo 060-8556, Japan.
Furuhata T; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo 060-8556, Japan.
Takemasa I; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo 060-8556, Japan.
Patel P; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Vora HH; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Shah B; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Patel JB; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Rajvik KN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Pandya SJ; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Shukla SN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Wang Y; Institute for Cancer Research, School of Basic Medical Science, Xi'an 710061, China.; Health Science Center of Xi'an Jiaotong University, Xi'an 710061, China.
Zhang G; Institute for Cancer Research, School of Basic Medical Science, Xi'an 710061, China.
Kawakami Y; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Marincola FM; Kite Pharma, Santa Monica, CA 90404, USA.
Ascierto PA; Melanoma Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy.
Fox BA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USA.
Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Galon J; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2023 Jan 08; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 08.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Proposal of a T3 Subclassification for Colon Carcinoma.
Autorzy:: Merkel S; Department of Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.
Brunner M; Department of Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.
Geppert CI; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Grützmann R; Department of Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.
Weber K; Department of Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.
Agaimy A; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), 91054 Erlangen, Germany.; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Dec 14; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer.
Autorzy:: Beck M; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Semrau S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Haderlein M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Gostian AO; Department of Otolaryngology-Head & Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Hartwich J; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Müller S; Department of Otolaryngology-Head & Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Kallies A; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Geppert CI; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Schonath M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Putz F; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Gaipl U; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Frey B; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Saake M; Department of Diagnostic Radiology, University Hospital of Erlangen, 91054 Erlangen, Bavaria, Germany.
Iro H; Department of Otolaryngology-Head & Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Uder M; Department of Diagnostic Radiology, University Hospital of Erlangen, 91054 Erlangen, Bavaria, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Kuwert T; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Eckstein M; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.
Hecht M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Bavaria, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Sep 30; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 30.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
Autorzy:: Mlecnik B; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Inovarion, 75005 Paris, France.
Torigoe T; Department of Pathology, Sapporo Medical University, Sapporo 060-8556, Japan.
Bindea G; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Popivanova B; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Xu M; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Fujita T; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Hazama S; Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Yamaguchi 755-8505, Japan.
Suzuki N; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, Japan.
Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, Japan.
Okuno K; Department of Surgery, Kindai University, School of Medicine, Osakasayama 589-0014, Japan.
Hirohashi Y; Department of Pathology, Sapporo Medical University, Sapporo 060-8556, Japan.
Furuhata T; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo 060-8556, Japan.
Takemasa I; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University, Sapporo 060-8556, Japan.
Patel P; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Vora H; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Shah B; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Patel JB; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Rajvik KN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Pandya SJ; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Shukla SN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad 380016, India.
Wang Y; Institute for Cancer Research, School of Basic Medical Science, Xi'an 710061, China.; Health Science Center of Xi'an Jiaotong University, Xi'an 710061, China.
Zhang G; Institute for Cancer Research, School of Basic Medical Science, Xi'an 710061, China.; Health Science Center of Xi'an Jiaotong University, Xi'an 710061, China.
Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwanoha, Kashiwa-shi 277-8577, Japan.
Taniguchi H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwanoha, Kashiwa-shi 277-8577, Japan.
Bifulco C; Department of Pathology, Providence Portland Medical Center, Portland, OR 97213, USA.
Lugli A; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Lee JJ; Department of Biostatistics, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.
Zlobec I; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Rau TT; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Berger MD; Department of Medical Oncology, University Hospital of Bern, 3010 Bern, Switzerland.
Nagtegaal ID; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Vink-Börger E; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Hartmann A; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Geppert CI; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Kolwelter J; Department of Pathology, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Merkel S; Department of Surgery, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Grützmann R; Department of Surgery, University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Van den Eynde M; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires St-Luc, 1200 Brussels, Belgium.; Institut de Recherche Clinique et Experimentale (Pole MIRO), Université Catholique de Louvain, 1200 Brussels, Belgium.
Jouret-Mourin A; Department of Pathology, Cliniques Universitaires St-Luc, 1200 Brussels, Belgium.; Institut de Recherche Clinique et Experimentale (Pole GAEN), Université Catholique de Louvain, 1200 Brussels, Belgium.
Kartheuser A; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Léonard D; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Remue C; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, 1200 Brussels, Belgium.
Wang J; Curandis, New York, NY 10583, USA.; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Bavi P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Roehrl MHA; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ohashi PS; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Nguyen LT; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Han S; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
MacGregor HL; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Hafezi-Bakhtiari S; Department of Pathology, Laboratory Medicine Program, University Health Network, 11-E444, Toronto, ON M5G 2C4, Canada.
Wouters BG; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Masucci GV; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, 17177 Stockholm, Sweden.
Andersson E; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, 17177 Stockholm, Sweden.
Zavadova E; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Vocka M; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Spacek J; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Petruzelka L; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Konopasek B; Department of Oncology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Dundr P; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Skalova H; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Nemejcova K; Institute of Pathology, First Faculty of Medicine, General University Hospital in Prague, Charles University, 12808 Prague, Czech Republic.
Botti G; Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
Tatangelo F; Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
Delrio P; Colorectal Surgery Department, Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.
Ciliberto G; IRCCS Istituto Nazionale Tumori 'Regina Elena', 00128 Rome, Italy.
Maio M; Center for Immuno-Oncology, University Hospital, 53100 Siena, Italy.
Laghi L; Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20090 Milan, Italy.; Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Grizzi F; Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Rozzano, 20090 Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
Marliot F; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Fredriksen T; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Buttard B; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Lafontaine L; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Maby P; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Majdi A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
Hijazi A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.
El Sissy C; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Kirilovsky A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Berger A; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Digestive Surgery Department, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Lagorce C; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Department of Pathology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Paustian C; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Ballesteros-Merino C; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.
Dijkstra J; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Van de Water C; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
van Lent-van Vliet S; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Knijn N; Pathology Department, Radboud University, 6500 HC Nijmegen, The Netherlands.
Mușină AM; Department of Surgical Oncology, Regional Institute of Oncology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iaşi, Romania.
Scripcariu DV; Department of Surgical Oncology, Regional Institute of Oncology, University of Medicine and Pharmacy 'Grigore T. Popa', 700115 Iaşi, Romania.
Marincola FM; Kite Pharma, Santa Monica, CA 90404, USA.
Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', 80131 Naples, Italy.
Fox BA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USA.
Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, 75015 Paris, France.
Kawakami Y; Division of Cellular Signaling, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo 160-8582, Japan.
Galon J; INSERM, Laboratory of Integrative Cancer Immunology, 75006 Paris, France.; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France.; Equipe Labellisée Ligue Contre le Cancer, 75006 Paris, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Sep 06; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 06.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice.
Autorzy:: Klepper S; Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.
Jung S; Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.
Dittmann L; Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, Friedrich-Alexander Universität Erlangen-Nürnberg, Krankenhausstr. 8, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander Universität Erlangen-Nürnberg, Krankenhausstr. 8, 91054 Erlangen, Germany.
Beier N; Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.
Trollmann R; Division of Pediatric Neurology, Department of Pediatrics, Friedrich-Alexander Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Aug 04; Vol. 23 (15). Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Injuries*/drug therapy
Brain Injuries*/etiology
Erythropoietin*/pharmacology
Neuroprotective Agents*/pharmacology
Neuroprotective Agents*/therapeutic use
Animals ; Animals, Newborn ; Endothelial Cells/metabolism ; Growth Hormone ; Humans ; Hypoxia/drug therapy ; Mice ; Occludin/metabolism ; Recombinant Proteins/pharmacology ; Vascular Endothelial Growth Factor A/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model.
Autorzy:: Kunze P; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Kreiss L; Institute of Medical Biotechnology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 3, 91052 Erlangen, Germany.; Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 7, 91052 Erlangen, Germany.; Clinics of Medicine I, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Novosadová V; Czech Center for Phenogenomics, Institute of Molecular Genetics of the ASCR, 142 20 Prague, Czech Republic.
Roehe AV; Department of Pathology and Legal Medicine, Federal University of Health Sciences of Porto Alegre, Porto Alegre 90050-170, Brazil.
Steinmann S; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Prochazka J; Czech Center for Phenogenomics, Institute of Molecular Genetics of the ASCR, 142 20 Prague, Czech Republic.
Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Schürmann S; Institute of Medical Biotechnology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 3, 91052 Erlangen, Germany.; Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 7, 91052 Erlangen, Germany.
Friedrich O; Institute of Medical Biotechnology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 3, 91052 Erlangen, Germany.; Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander University Erlangen-Nürnberg (FAU), Paul-Gordan-Str. 7, 91052 Erlangen, Germany.; School of Mechanical, Medical & Process Engineering, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
Schneider-Stock R; Experimental Tumor Pathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 May 10; Vol. 14 (10). Date of Electronic Publication: 2022 May 10.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Impact of Endothelial Progenitor Cells in the Vascularization of Osteogenic Scaffolds.
Autorzy:: Steiner D; Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Reinhardt L; Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Fischer L; Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Popp V; Preclinical Imaging Platform Erlangen (PIPE), Institute of Radiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Körner C; Department of Materials Science and Engineering, Institute of Science and Technology of Metals, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91058 Erlangen, Germany.
Geppert CI; Institute of Pathology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Bäuerle T; Preclinical Imaging Platform Erlangen (PIPE), Institute of Radiology, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Horch RE; Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Arkudas A; Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Mar 08; Vol. 11 (6). Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Endothelial Progenitor Cells*
Mesenchymal Stem Cells*
Bone Regeneration ; Fibrin ; Osteogenesis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes.
Autorzy:: Pour Farid P; Experimental Tumorpathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Institute of Pathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Eckstein M; Institute of Pathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Merkel S; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Department of Surgery, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Grützmann R; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Department of Surgery, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Bruns V; Fraunhofer Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.
Benz M; Fraunhofer Institute for Integrated Circuits IIS, Am Wolfsmantel 33, 91058 Erlangen, Germany.
Schneider-Stock R; Experimental Tumorpathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Institute of Pathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center-EMN (CCC), University Hospital, Friedrich-Alexander-University of Erlangen-Nüremberg (FAU), 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 03; Vol. 22 (23). Date of Electronic Publication: 2021 Dec 03.
Typ publikacji:: Journal Article
MeSH Terms:: Adenocarcinoma, Mucinous/*pathology
Carcinoma, Medullary/*pathology
Carcinoma, Signet Ring Cell/*pathology
Colonic Neoplasms/*pathology
Adenocarcinoma, Mucinous/metabolism ; Biomarkers, Tumor/metabolism ; Carcinoma, Medullary/metabolism ; Carcinoma, Signet Ring Cell/metabolism ; Colonic Neoplasms/metabolism ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Tissue Array Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes.
Autorzy:: Erber R; Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Kailayangiri S; Department of Pediatric Hematology and Oncology, Münster University Hospital, 48149 Münster, Germany.
Huebner H; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Ruebner M; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Häberle L; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.; Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.
Meyer J; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.; Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.
Völkl S; Department of Internal Medicine 5, Hematology/Oncology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Mackensen A; Department of Internal Medicine 5, Hematology/Oncology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Landgraf L; Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Schulz-Wendtland R; Institute of Diagnostic Radiology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Farwick N; Department of Pediatric Hematology and Oncology, Münster University Hospital, 48149 Münster, Germany.
Rossig C; Department of Pediatric Hematology and Oncology, Münster University Hospital, 48149 Münster, Germany.
Gass P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Nov 08; Vol. 13 (21). Date of Electronic Publication: 2021 Nov 08.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients.
Autorzy:: Weyerer V; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.
Strissel PL; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Adjunct Affiliation With Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Strick R; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Sikic D; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Bertz S; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Lange F; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Taubert H; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Wach S; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Breyer J; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology, University Hospital Regensburg, University of Regensburg, 93053 Regensburg, Germany.
Bolenz C; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University of Ulm, 89081 Ulm, Germany.
Erben P; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology, University Hospital Mannheim, Rupprecht-Karls-Universität Heidelberg, 68177 Mannheim, Germany.
Schmitz-Draeger BJ; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Urologie 24, 90431 Nuremberg, Germany.
Wullich B; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.
Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.; BRIDGE-Consortium Germany e.V., 68177 Mannheim, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 May 12; Vol. 13 (10). Date of Electronic Publication: 2021 May 12.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Autorzy:: Semrau S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Gostian AO; Department of Otorhinolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Traxdorf M; Department of Otorhinolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Eckstein M; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Rutzner S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
von der Grün J; Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt am Main, 60323 Hessen, Germany.
Illmer T; Medical Oncology Clinic Dresden Freiberg, Dresden, 01307 Sachsen, Germany.
Hautmann M; Department of Radiation Oncology, Universität Regensburg, Regensburg, 93040 Bayern, Germany.
Klautke G; Department of Radiation Oncology, Chemnitz Hospital, Chemnitz, 09112 Sachsen, Germany.
Laban S; Department of Otorhinolaryngology and Head & Neck Surgery, Universitätsklinikum Ulm, Ulm, 89081 Baden-Württemberg, Germany.
Brunner T; Department of Radiation Oncology, Otto von Guericke Universität Magdeburg, Sachsen-Anhalt, 39120 Magdeburg, Germany.
Tamaskovics B; Department of Radiation Oncology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, 40210 Nordrhein-Westfalen, Germany.
Frey B; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Zhou JG; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
Geppert CI; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Balermpas P; Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt am Main, 60323 Hessen, Germany.
Budach W; Department of Radiation Oncology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, 40210 Nordrhein-Westfalen, Germany.
Gaipl U; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Iro H; Department of Otorhinolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.
Hecht M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054 Bayern, Germany.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Apr 19; Vol. 13 (8). Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Extracorporeal perfusion - reduced to a one-way infusion.
Autorzy:: Taeger CD; Department of Plastic and Hand Surgery, University Hospital of Regensburg, Regensburg, Germany.
Friedrich O; Institute of Medical Biotechnology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Horch RE; Department of Plastic and Hand Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Drechsler C; Department of Plastic and Hand Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Weigand A; Department of Plastic and Hand Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Hopf F; Institute of Bioprocess Engineering, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Geppert CI; Pathology and Anatomy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Münch F; Department of Paediatric Cardiac Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Birkholz T; Department of Anaesthesiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Wenzel C; Department of Plastic and Hand Surgery, University Hospital of Regensburg, Regensburg, Germany.
Geis S; Department of Plastic and Hand Surgery, University Hospital of Regensburg, Regensburg, Germany.
Prantl L; Department of Plastic and Hand Surgery, University Hospital of Regensburg, Regensburg, Germany.
Buchholz R; Institute of Bioprocess Engineering, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Präbst K; Institute of Bioprocess Engineering, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Pokaż więcej
Źródło:: Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2021; Vol. 79 (2), pp. 257-267.
Typ publikacji:: Journal Article
MeSH Terms:: Perfusion*/methods
Plastic Surgery Procedures*/adverse effects
Plastic Surgery Procedures*/methods
Humans ; Ischemia/etiology ; Ischemia/prevention & control ; Organ Preservation

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
Autorzy:: Hülsen S; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Lippolis E; Institute of Human Genetics, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Ferrazzi F; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.; Institute of Human Genetics, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.; Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Otto W; Caritas St. Josef Medical Center, Department of Urology, Regensburg University, 93053 Regensburg, Germany.
Distel L; Department of Radiation Therapy, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Fietkau R; Department of Radiation Therapy, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Denzinger S; Caritas St. Josef Medical Center, Department of Urology, Regensburg University, 93053 Regensburg, Germany.
Breyer J; Caritas St. Josef Medical Center, Department of Urology, Regensburg University, 93053 Regensburg, Germany.
Burger M; Caritas St. Josef Medical Center, Department of Urology, Regensburg University, 93053 Regensburg, Germany.
Bertz S; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Eckstein M; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Ebner A; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Geppert CI; Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, 91054 Erlangen, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2020 Nov 09; Vol. 21 (21). Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphocytes, Tumor-Infiltrating/*immunology
Urinary Bladder Neoplasms/*immunology
Urinary Bladder Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Biomarkers/metabolism ; CD3 Complex/immunology ; CD8-Positive T-Lymphocytes/immunology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging/methods ; Prognosis ; Tumor Microenvironment/immunology ; Urinary Bladder Neoplasms/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Geppert CI"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język